Govt Panel Nod To Zydus Cadila’s 3-dose COVID Vaccine ZyCov-D
It showed an efficacy rate of 66.6% in a late-stage trial of more than 28,000 volunteers nationwide. It also said the vaccine is safe for children between 12 and 18 years of age.
It showed an efficacy rate of 66.6% in a late-stage trial of more than 28,000 volunteers nationwide. It also said the vaccine is safe for children between 12 and 18 years of age.
If approved, ZyCoV-D would be the fifth vaccine allowed for emergency use in the country.
Dr VK Paul, Member-Health, Niti Aayog on being asked when Zydus Cadila’s COVID vaccine for children will be available said, “DCGI is examining it. More data is needed.”
While most COVID-19 vaccines are given in two doses, the plasmid vaccine will be given in three doses, with an interval of 28 days between the first and second and second and third shots.
If approved, the Zydus Cadila vaccine will be available for administration in children aged 12 and above.